08/18/2026

WPS Oncology Related LCD Updates

August Updates

Local Coverage Determination (LCD) and Billing and Coding Article Updates 

We updated the following Local Coverage Determinations (LCDs) and Billing and Coding Articles for August 2026. The full article on our website details additional information on these updates.  

Please note: Our LCDs and Billing and Coding/Coverage articles will reflect these changes on July 30, 2026.

New Policies/Articles – We created the following new policies/articles for August 2026 – Effective August 30, 2026: 

• Billing and Coding: MolDx: Molecular Testing for Solid Organ Allograft Rejection 
• MolDx: Molecular Testing for Solid Organ Allograft Rejection
• Response to Comments MolDx: Molecular Testing for Solid Organ Allograft Rejection

Retired Policies/Articles – We retired the following policies/articles for August 2026 – Effective August 29, 2026:

• Billing and Coding: MolDx: Molecular Testing for Solid Organ Allograft Rejection 
• MolDx: Molecular Testing for Solid Organ Allograft Rejection

Revised Policies/Articles – We revised the following policies/articles for August 2026 – Effective as Indicated 

• Billing and Coding: Immune Globulins – Effective July 1, 2026
• Billing and Coding: MOHS Micrographic Surgery – Effective July 30, 2026
• Billing and Coding: MolDx: Molecular Diagnostic Tests (MDT) – Effective July 1, 2026
• Billing and Coding: MolDx: Pharmacogenomics Testing – Effective July 1, 2026
• Billing and Coding: MolDx: Proteomics Testing – Effective July 1, 2026
• Billing and Coding: MolDx: Repeat Germline Testing – Effective July 1, 2026
• Billing and Coding: Removal of Benign Skin Lesions – Effective July 30, 2026

Self-Administered Drug Exclusion List (SAD List) – Effective August 29, 2026